|
Volumn 16, Issue 12, 2005, Pages 2195-2196
|
Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
HEPARANASE;
BONE METASTASIS;
BONE TURNOVER;
BREAST CARCINOMA;
CANCER DIAGNOSIS;
CANCER GROWTH;
CANCER INVASION;
CANCER PATIENT;
CANCER TISSUE;
ENZYME BLOOD LEVEL;
HUMAN;
LETTER;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TUMOR VASCULARIZATION;
BONE NEOPLASMS;
BREAST NEOPLASMS;
FEMALE;
GLUCURONIDASE;
HUMANS;
OSTEOPOROSIS;
RISK FACTORS;
|
EID: 29044439308
PISSN: 0937941X
EISSN: 14332965
Source Type: Journal
DOI: 10.1007/s00198-005-2034-x Document Type: Letter |
Times cited : (2)
|
References (6)
|